Home Biosimilar Antibodies Protein Tyrosine Kinase EGFR Amivantamab (Anti-HGFR / c-Met) For research use only.
Not for use in humans.

Amivantamab (Anti-HGFR / c-Met)

Synonyms: JNJ-61186372

Amivantamab (Anti-HGFR / c-Met) is a human bispecific antibody targeting EGFR-MET.It has immune anticancer activity in non-small cell lung cancer (NSCLC). MW :146.1 KD.

Amivantamab (Anti-HGFR / c-Met)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 5.61mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective EGFR Inhibitors

Biological Activity

Description Amivantamab (Anti-HGFR / c-Met) is a human bispecific antibody targeting EGFR-MET.It has immune anticancer activity in non-small cell lung cancer (NSCLC). MW :146.1 KD.

Product Details

CAS No. 2171511-58-1
Molecular Weight 146.1
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Amivantamab (Anti-HGFR / c-Met) | Amivantamab (Anti-HGFR / c-Met) supplier | purchase Amivantamab (Anti-HGFR / c-Met) | Amivantamab (Anti-HGFR / c-Met) cost | Amivantamab (Anti-HGFR / c-Met) manufacturer | order Amivantamab (Anti-HGFR / c-Met) | Amivantamab (Anti-HGFR / c-Met) distributor